维普中文期刊产品整合服务
28篇 您的检索式:作者名="Mayer IA"
    题名 作者 年代 出处 被引量
1The PI3K/AKT pathway as a target for cancer treatment显示文摘Mayer IA Arteaga CL 2016Annu Rev Med2016,67,3:1
2Stand up to cancer phase Ib study of pan - phosphoinositide - 3 - kinase inhibitor buparlisib with letrozole in estrogen receptor - positive/human epidermal growth factor receptor 2 - negative metastatic breast cancer显示文摘Mayer IA Abramson VG Isakoff SJ 2014J Clin Oncol2014,32,12:1
3Multicenter phaseⅡstudy of neoadjuvant lapatinib and trastuzumab with hormonal therapy and without chemotherapy in patients with human epidermal growth factor receptor 2-overexpressing breast cancer: TBCRC 006显示文摘Rimawi MF Mayer IA Forero A 2013J Clin Oncol2013,31,14:1
4Molecular heterogeneity of triple nega- tive breast cancer 显示文摘Abramson VG Mayer IA 2014Current Breast Cancer Reports2014,6,:1
5Misdiagnosis of symptomatic cerebral aneurysm:prevalence and correlation with outcome at four in stitutions显示文摘Mayer PL Awad IA Todor R 1996Stroke1996,27,:1
6The p38 MAPK pathway mediates the growth inhibitory effects of interferon-alpha in BCR- ABL-expressing cells 显示文摘Mayer IA Verma A Grumbach IM 2001J Biol Chem2001,276,28:1
7New strategies for triple-negative breast cancer--deciphering the heterogeneity 显示文摘Mayer IA Abramson VG Lehmann BD 2014Clin Cancer Res2014,20,4:1
8New strategies for triple-negative breast cancer--deciphering the heterogeneity显示文摘Mayer IA Abramson VG Lehmann BD 2014Clin Cancer Res2014,20,4:1
9The p38 MAPK pathway mediates the growth inhibitory effects of interferon- alpha in BCR-ABL-expressing cells 显示文摘Mayer IA Verma A Grumbach IM 2001J Biol Chem2001,276,28:1
10Gefitinib and celecoxib in advanced metastatic gastrointestinal tumors: a pilot feasibility study显示文摘Yamaguchi NH Mayer IA Malzyner A 2014J Gastrointest Oncol2014,5,1:1
11Toward a global phylogeny of the Brassicaceae显示文摘Bailey CD Koch MA Mayer M Mummenhoff K O'Kane SL Warwick SI Windham MD Al-Shehbaz IA 0,,:1
12Misdiagnosis of Symptomatic cerebral aneurysm: prevalence and corrdlation With outcome at four institution显示文摘Mayer PL Awad IA TodorR 1996Stroke1996,27,:1
13The p38 MAPK pathway mediates the growth inhibitory effects of interferonalpha in BCR-ABL-expressing cells显示文摘Mayer IA Verma A Grumbach IM 2001J Biol Chem2001,276,28:1
14Discordant cellular re- sponse to presurgical letrozole in bilateral synchronous ER + breast cancers with a KRAS mutation or FGFRI gene amplifica- tion 显示文摘Balko JM Mayer IA Sanders ME 2012Mol Cancer Ther2012,11,10:1
15The PI3K/AKT pathway as a tar-get for cancer treatment 显示文摘Mayer IA Arteaga CL 2016Annu Rev Med2016,67,:1
16Misdiagnos is of symptomat in cerebral aneurysm: prevalence and corrdlation with outcome at four institution 显示文摘Mayer PL Awad IA Todor R 1996Stroke1996,27,:1
17New Strategies for Triple-Negative Breast Cancer--Decipher- ing the Heterogeneity显示文摘Mayer IA Abramson VG Lehmann BD 2014Clin Cancer Res2014,20,4:1
18Antiangiogenic therapies in early- stage breast cancer显示文摘Derleth C Mayer IA 2010Clin Breast Cancer2010,10,1:1
19Antiangiogenic therapies in early-stage breast cancer 显示文摘Derleth C Mayer IA 2010Clin Breast Cancer2010,10,1:1
20Antiangiogenic therapies in early-stage br- east cancer显示文摘Derleth C Mayer IA 2010Clin Breast Cancer2010,10,1:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费